Ebix (NASDAQ: EBIX) and Imprivata (NYSE:IMPR) are both computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, valuation, institutional ownership, dividends, risk and analyst recommendations.


This table compares Ebix and Imprivata’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Ebix 30.69% 22.02% 11.93%
Imprivata -17.22% -58.85% -22.17%


Ebix pays an annual dividend of $0.30 per share and has a dividend yield of 0.5%. Imprivata does not pay a dividend. Ebix pays out 9.8% of its earnings in the form of a dividend.

Volatility and Risk

Ebix has a beta of 1.76, meaning that its share price is 76% more volatile than the S&P 500. Comparatively, Imprivata has a beta of -1.21, meaning that its share price is 221% less volatile than the S&P 500.

Earnings and Valuation

This table compares Ebix and Imprivata’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Ebix $321.14 million 5.56 $114.36 million $3.07 18.50
Imprivata N/A N/A N/A ($0.93) -20.71

Ebix has higher revenue and earnings than Imprivata. Imprivata is trading at a lower price-to-earnings ratio than Ebix, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

65.3% of Ebix shares are held by institutional investors. Comparatively, 59.3% of Imprivata shares are held by institutional investors. 13.0% of Ebix shares are held by insiders. Comparatively, 40.2% of Imprivata shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Ebix and Imprivata, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ebix 0 0 1 0 3.00
Imprivata 0 0 0 0 N/A


Ebix beats Imprivata on 9 of the 11 factors compared between the two stocks.

About Ebix

Ebix, Inc. (Ebix) is a supplier of software and e-commerce solutions to the insurance industry. Ebix provides application software products for the insurance industry, including carrier systems, agency systems and exchanges, as well as custom software development. Ebix conducts its operations through four channels, which include Exchanges, Carrier Systems, Broker Systems and Risk Compliance Solutions (RCS). Ebix operates data exchanges in the areas of life insurance, annuities, employee health benefits, risk management, workers compensation, and property and casualty (P&C) insurance. Ebix designs and deploys back-end systems for P&C insurance brokers across the world. Ebix also designs and deploys on-demand and back-end systems for P&C insurance companies. Ebix focus in RCS channel pertains to business process outsourcing services that include providing project management, time and material consulting to clients across the world, and claims adjudication/settlement services.

About Imprivata

Imprivata, Inc. (Imprivata) is a United States-based healthcare information technology security company. The Company enables healthcare organizations to access, communicate and transact patient information securely. The Company offers Imprivata OneSign, Imprivata Cortext, Imprivata Confirm ID and Imprivata PatientSecure. Imprivata OneSign provides single sign-on, authentication management and virtual desktop roaming, enabling No Click Access to clinical applications and patient information, anytime, anywhere and from any device. Imprivata Cortext enables clinicians to collaborate across care teams and organizations. Imprivata Confirm ID is an identity and two-factor authentication platform for remote access, electronic prescriptions for controlled substances (EPCS), medical device access and other clinical authentication workflows. Imprivata PatientSecure is a patient identification solution that uses palm vein recognition biometrics to identify patients at any point of entry to care.

Receive News & Ratings for Ebix Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ebix Inc. and related companies with MarketBeat.com's FREE daily email newsletter.